Legal DealFolio - Hologic acquisition of Gen-Probe Incorporated

The Firm is representing Goldman, Sachs & Co. as financial advisor to Hologic, Inc, in its acquisition of Gen-Probe Incorporated. Under the terms of the agreement, Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value at approximately $3.7 billion. The transaction is expected to close in the second half of 2012, subject to customary closing conditions. Hologic (NASDAQ: HOLX) is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Gen-Probe (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. The Simpson Thacher team includes Rob Spatt, Brian Stadler, Thomas Lamprecht and Matt Rogers.

Deal Date:	03-05-2012	Practice Area:	Corporate and M&A
Deal Title:	Hologic acquisition of Gen-Probe Incorporated	Industry:	Healthcare Equipment & Services
Description:	The Firm is representing Goldman, Sachs & Co. as financial advisor to Hologic, Inc, in its acquisition of Gen-Probe Incorporated. Under the terms of the agreement, Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value at approximately $3.7 billion. The transaction is expected to close in the second half of 2012, subject to customary closing conditions. Hologic (NASDAQ: HOLX) is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Gen-Probe (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. The Simpson Thacher team includes Rob Spatt, Brian Stadler, Thomas Lamprecht and Matt Rogers.
Financial Center:	New York	Value:	1000.01-5000.00
Advised Party:	Financial Advisors	Law Firm	Simpson Thacher
Target Company Jurisdiction:	United States	Acquiror Jurisdiction:	United States
Classification:	Strategic Buyer Acquisitions Private Company	Lawyer	Robert E Spatt

Practice Areas -

Corporate and M&A Law Firms and Lawyers

Practice Areas - Corporate and M&A Law Firms and Lawyers